Thai pharma company partners with Cuban firm

by -
1990

Cuba medical centerIn the first move of its kind, a Thai biopharmaceutical company on April 29 signed a technology transfer pact with Cuba’s Center of Molecular Immunology to produce drugs to treat cancer and autoimmune diseases.

The agreement was signed between the Siam Bioscience Company and the Cuban center, which was set up in 1994 to research and manufacture “off-patent biopharmaceuticals.”

The specialised medical field uses genetic engineering to produce new medicines, most of which remain inaccessible to developing countries because of their high production costs.

“In Cuba we made the first steps in biotechnology early in the ’80s,under the direct leadership of President Fidel Castro,” said Agustin Lage Devila, director general of the Center of Molecular Immunology.

“However, no country can face this enormous challenge alone,” he said. “International cooperation is needed, especially joint projects among developing countries.”

In Thailand, the center agreed to make Siam Bioscience its contract manufacturer of biopharmaceuticals to treat lymphoma, breast cancer and autoimmune diseases, which include arthritis and multiple sclerosis.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

In the first move of its kind, a Thai biopharmaceutical company on April 29 signed a technology transfer pact with Cuba's Center of Molecular Immunology to produce drugs to treat cancer and autoimmune diseases. The agreement was signed between the Siam Bioscience Company and the Cuban center, which was set up in 1994 to research and manufacture "off-patent biopharmaceuticals." The specialised medical field uses genetic engineering to produce new medicines, most of which remain inaccessible to developing countries because of their high production costs. "In Cuba we made the first steps in biotechnology early in the ’80s,under the direct leadership...

Cuba medical centerIn the first move of its kind, a Thai biopharmaceutical company on April 29 signed a technology transfer pact with Cuba’s Center of Molecular Immunology to produce drugs to treat cancer and autoimmune diseases.

The agreement was signed between the Siam Bioscience Company and the Cuban center, which was set up in 1994 to research and manufacture “off-patent biopharmaceuticals.”

The specialised medical field uses genetic engineering to produce new medicines, most of which remain inaccessible to developing countries because of their high production costs.

“In Cuba we made the first steps in biotechnology early in the ’80s,under the direct leadership of President Fidel Castro,” said Agustin Lage Devila, director general of the Center of Molecular Immunology.

“However, no country can face this enormous challenge alone,” he said. “International cooperation is needed, especially joint projects among developing countries.”

In Thailand, the center agreed to make Siam Bioscience its contract manufacturer of biopharmaceuticals to treat lymphoma, breast cancer and autoimmune diseases, which include arthritis and multiple sclerosis.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00